1 Hr
Source:
المشهد
المشهد
Ready to play
Ready to play
Researchers at the American Association for the Study of Liver Diseases conference in Denver announced an experimental blood test called “Liquid Transformer.” It identifies stages of chronic liver damage without a biopsy by analyzing DNA in the bloodstream. The results showed that its accuracy is close to that of MRI, and that it helps identify patients eligible for treatment. It can also distinguish among three forms of fatty liver disease. The researchers say the test outperformed other alternatives, but its results remain experimental.
Notice: This Is an AI-Generated Summary
Comments (0)